Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doris Trapin

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Ebiomedicine|April 22, 2018
Genetic restriction of antigen-presentation dictates allergic sensitization and disease in humanized miceAlina Neunkirchner, Bernhard Kratzer, Cordula Köhler, et al.
Scientific Reports|February 8, 2017
Chloroquine inhibits human CD4<sup>+</sup> T-cell activation by AP-1 signaling modulationRalf L J Schmidt, Sabrina Jutz, Katrin Goldhahn, et al.
Frontiers in Immunology|April 24, 2023
The small molecule inhibitor BX-795 uncouples IL-2 production from inhibition of Th2 inflammation and induces CD4<sup>+</sup> T cells resembling iTregPeter A Tauber, Bernhard Kratzer, Philipp Schatzlmaier, et al.
Allergy|July 24, 2018
Prevention of allergy by virus-like nanoparticles (VNP) delivering shielded versions of major allergens in a humanized murine allergy modelBernhard Kratzer, Cordula Köhler, Sandra Hofer, et al.
British Journal of Haematology|August 30, 2023
Evans syndrome caused by a deleterious mutation affecting the adaptor protein SASH3Wolfgang Novak, Jakob Berner, Michael Svaton, et al.
Allergy|March 31, 2022
Vaccine based on folded receptor binding domain-PreS fusion protein with potential to induce sterilizing immunity to SARS-CoV-2 variantsPia Gattinger, Bernhard Kratzer, Inna Tulaeva, et al.
Vaccines|April 27, 2024
Flow Cytometry-Based Measurement of Antibodies Specific for Cell Surface-Expressed Folded SARS-CoV-2 Receptor-Binding DomainsAl Nasar Ahmed Sehgal, Jera Safran, Bernhard Kratzer, et al.
Allergy|July 14, 2024
Differential decline of SARS-CoV-2-specific antibody levels, innate and adaptive immune cells, and shift of Th1/inflammatory to Th2 serum cytokine levels long after first COVID-19Bernhard Kratzer, Pia Gattinger, Doris Trapin, et al.
Allergy|October 31, 2020
Immunological imprint of COVID-19 on human peripheral blood leukocyte populationsBernhard Kratzer, Doris Trapin, Paul Ettel, et al.
Frontiers in Immunology|October 17, 2025
Severe COVID-19 induces prolonged elevation of the acute-phase protein pentraxin 3Bernhard Kratzer, Robert B Stieger, Seyma Durmus, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Ebiomedicine|April 22, 2018
Genetic restriction of antigen-presentation dictates allergic sensitization and disease in humanized miceAlina Neunkirchner, Bernhard Kratzer, Cordula Köhler, et al.
Scientific Reports|February 8, 2017
Chloroquine inhibits human CD4<sup>+</sup> T-cell activation by AP-1 signaling modulationRalf L J Schmidt, Sabrina Jutz, Katrin Goldhahn, et al.
Frontiers in Immunology|April 24, 2023
The small molecule inhibitor BX-795 uncouples IL-2 production from inhibition of Th2 inflammation and induces CD4<sup>+</sup> T cells resembling iTregPeter A Tauber, Bernhard Kratzer, Philipp Schatzlmaier, et al.
Allergy|July 24, 2018
Prevention of allergy by virus-like nanoparticles (VNP) delivering shielded versions of major allergens in a humanized murine allergy modelBernhard Kratzer, Cordula Köhler, Sandra Hofer, et al.
British Journal of Haematology|August 30, 2023
Evans syndrome caused by a deleterious mutation affecting the adaptor protein SASH3Wolfgang Novak, Jakob Berner, Michael Svaton, et al.
Allergy|March 31, 2022
Vaccine based on folded receptor binding domain-PreS fusion protein with potential to induce sterilizing immunity to SARS-CoV-2 variantsPia Gattinger, Bernhard Kratzer, Inna Tulaeva, et al.
Vaccines|April 27, 2024
Flow Cytometry-Based Measurement of Antibodies Specific for Cell Surface-Expressed Folded SARS-CoV-2 Receptor-Binding DomainsAl Nasar Ahmed Sehgal, Jera Safran, Bernhard Kratzer, et al.
Allergy|July 14, 2024
Differential decline of SARS-CoV-2-specific antibody levels, innate and adaptive immune cells, and shift of Th1/inflammatory to Th2 serum cytokine levels long after first COVID-19Bernhard Kratzer, Pia Gattinger, Doris Trapin, et al.
Allergy|October 31, 2020
Immunological imprint of COVID-19 on human peripheral blood leukocyte populationsBernhard Kratzer, Doris Trapin, Paul Ettel, et al.
Frontiers in Immunology|October 17, 2025
Severe COVID-19 induces prolonged elevation of the acute-phase protein pentraxin 3Bernhard Kratzer, Robert B Stieger, Seyma Durmus, et al.
Pageof 3